Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
famciclovir, Quantity: 500 mg
Arrotex Pharmaceuticals Pty Ltd
Famciclovir
Tablet, film coated
Excipient Ingredients: silicon dioxide; copovidone; microcrystalline cellulose; sodium stearylfumarate; crospovidone; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate
Oral
12 tablets, 4 tablets, 30 tablets, 9 tablets, 14 tablets, 56 tablets, 3 tablets, 16 tablets, 20 tablets
(S4) Prescription Only Medicine
Famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours.,Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. Famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,Famciclovir is also indicated for suppression of recurrent genital herpes.,Famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,Famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex
Visual Identification: White, oval, coated tablets debossed with FM on one side and 500 on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2017-02-24